White matter hyperintensities predict amyloid increase in Alzheimer's disease-Reference-Cited by-同舟云学术

White matter hyperintensities predict amyloid increase in Alzheimer's disease

Published:2012-12 Issue:12 Volume:33 Page:2766-2773
ISSN:0197-4580
Container-title:Neurobiology of Aging
language:en
Short-container-title:Neurobiology of Aging

Author:

Grimmer Timo,Faust Maximilian,Auer Florian,Alexopoulos Panagiotis,Förstl Hans,Henriksen Gjermund,Perneczky Robert,Sorg Christian,Yousefi Behrooz H.,Drzezga Alexander,Kurz Alexander

Funder

Kommission Klinische Förderung

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Developmental Biology,Clinical Neurology,Ageing,General Neuroscience

Reference34 articles.

1. Neuropathological staging of Alzheimer-related changes;Braak;Acta Neuropathol,1991

2. Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease;Brickman;Arch. Neurol,2008

3. Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology;Carare;Neuropathol. Appl. Neurobiol,2008

4. Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance;Castellano;Sci. Transl. Med,2011

5. Interaction between hypertension, apoE, and cerebral white matter lesions;de Leeuw;Stroke,2004

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amyloid, Tau, and APOE in Alzheimer’s Disease: Impact on White Matter Tracts;2024-08-05

2. Association between retinal microvascular abnormalities and late-life brain amyloid-β deposition: the ARIC-PET study;Alzheimer's Research & Therapy;2024-05-06

3. Traumatic Brain Injury and Post-Traumatic Stress Disorder and Their Influence on Development and Pattern of Alzheimer’s Disease Pathology in Later Life;Journal of Alzheimer's Disease;2024-04-16

4. Upsetting the Balance: How Modifiable Risk Factors Contribute to the Progression of Alzheimer’s Disease;Biomolecules;2024-02-24

5. Cerebrovascular disease drives Alzheimer plasma biomarker concentrations in adults with Down syndrome;2023-11-29